Diligence memo · auto-generated · as of July 2, 2026

RxWare, Inc.

RxWare, Inc. looks fair against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 27.3× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

RxWare, Inc. operates in Other Health Care, based in WILMINGTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

RxWare, Inc. has raised $11M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.1M on 2025-08-01.

Most recent recorded round closed around 2025-08-01.

Valuation (modeled)modeled

Provath models RxWare, Inc. at approximately $20M (range $7.9M–$34M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.23× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 23 months.

Last raise 11 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 27.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 77% of Other Health Care peers (5377 compared).

Modeled value ranks above 48% of those peers.

Closest niche peers: HelloJoy, Inc., Maui Imaging, Inc., Celltrio, Inc., Medmo, Inc., Vertical Orthopaedics, Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.